A 44-year-old Chinese woman presented with a cutaneous eruption affecting the face and neck since the age of 16 years [ Figure 1a ]. The lesions were asymptomatic with no seasonal variation and had progressively increased over the years. She reported that her mother and sister had had similar but milder lesions since puberty [ Figure 1c ]. Cutaneous examination revealed diffuse erythema with numerous soft and umbilicated, 2 to 3 mm, skin colored papules on the face, neck, and upper thorax, sparing the periorbital, perioral and perinasal areas. Some papules were confluent and formed linear patterns. Her skin was greasy. Circulating androgens (testosterone, dehydroepiandrosterone and androstenedione) and urinary 17-ketosteroids were normal. A skin biopsy showed normal epidermis and lobules of mature sebaceous glands in the dermis [Figure 2a ]. Some sebaceous ducts opened into the epidermis [ Figure 2b ]. There was a mild perivascular lymphocytic infiltrate in the papillary dermis. These findings were consistent with a diagnosis of premature sebaceous hyperplasia (PSH). The patient was put on a trial of oral isotretinoin, 1 mg/kg daily for 12 weeks, resulting in significant reduction in size of the lesions and extent of facial seborrhea [ Figure 1b ]. The patient reported no side-effects of isotretinoin and no relapse was observed during the 3-month follow-up period after cessation of therapy.
Premature sebaceous hyperplasia, first reported in 1980, is a benign proliferation of sebaceous glands that appears at puberty or just afterwards and tends to become worse with age. [1] The disease has a predilection for males and is believed to have an autosomal do minant inheritance pattern. The lesions mostly occur on the face, neck and upper thorax. One of the characteristics is a lack of acneiform eruption. Histologically, there are hyperplastic and hypertrophic mature sebaceous glands, identical to those of sebaceous hyperplasia, filling the dermis. [2] The precise etiol ogy and pathogenesis of premature sebaceous hyperplasia remain unknown. [3] Hormonal factors were once thought to be important because most cases occur in men, but the growing incidence of the disease in women suggests there may be other factors playing a role in pathogenesis. [4] Our patient had a family history supporting genetic predisposition. However, until date, most reported cases have been sporadic. Therefore, larger case series and further research are needed to establish the etiological and pathophysiological processes of the condition.
Premature sebaceous hyperplasia may be misdiagnosed as rosacea clinically. However, histologically, the typical numerous, large sebaceous glands composed of mature sebocytes are absent in the dermis of rosacea.
Grimalt et al. reported that isotretinoin reduced the size of the sebaceous glands in 3 weeks and induced perifollicular fibrosis after 12 weeks of therapy. [5] Our patient was successfully treated with oral isotretinoin for 12 weeks. We speculate that her lack of relapse may be due to the perifollicular fibrosis secondary to isotretinoin therapy. 
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